Heliostatix

Curated by Signal

Developer of therapeutics for eye diseases

Overview

Heliostatix is developing therapeutics for eye diseases. The company has developed multiple products called lumenpro which contains lanosterol and NAC is useful for the treatment of cataract. The company has developing multiple formulations such as microbead formulations, and carrier molecule complexing formulation among others.

Key facts

Founded: 2018
Headquarters: Greenbelt, United States
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view
Commercial model: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

KwikVet
Provider of app for animal health monitoring
Health TechnologyWashington, DC, United States
Ilekun Health
AI-based platform for listing and finding healthcare providers
Health TechnologySan Francisco, United States
Clarity Health
Care Coordination Service for Healthcare organizations
Health TechnologySeattle, United States

About Heliostatix

What does Heliostatix do?

Heliostatix is developing therapeutics for eye diseases.

Where is Heliostatix headquartered?

Heliostatix is headquartered in Greenbelt, United States.

When was Heliostatix founded?

Heliostatix was founded in 2018.

Which sector is Heliostatix in?

Heliostatix operates in Health Technology.

Who are Heliostatix's competitors?

Companies similar to Heliostatix include KwikVet, Ilekun Health, and Clarity Health.